These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 8037887)

  • 1. Adverse effects of depolarising neuromuscular blocking agents. Incidence, prevention and management.
    Book WJ; Abel M; Eisenkraft JB
    Drug Saf; 1994 May; 10(5):331-49. PubMed ID: 8037887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse effects of nondepolarising neuromuscular blocking agents. Incidence, prevention and management.
    Abel M; Book WJ; Eisenkraft JB
    Drug Saf; 1994 Jun; 10(6):420-38. PubMed ID: 7917072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse effects of neuromuscular blockers and their antagonists.
    Naguib M; Magboul MM
    Middle East J Anaesthesiol; 1998 Jun; 14(5):341-73. PubMed ID: 9785339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromuscular transmission and its pharmacological blockade. Part 2: Pharmacology of neuromuscular blocking agents.
    Booij LH
    Pharm World Sci; 1997 Feb; 19(1):13-34. PubMed ID: 9089750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse effects of neuromuscular blockers and their antagonists.
    Naguib M; Magboul MM
    Drug Saf; 1998 Feb; 18(2):99-116. PubMed ID: 9512917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catastrophic hyperkalaemia following administration of suxamethonium chloride to a patient with undiagnosed amyotrophic lateral sclerosis.
    Turner MR; Lawrence H; Arnold I; Ansorge O; Talbot K
    Clin Med (Lond); 2011 Jun; 11(3):292-3. PubMed ID: 21902090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suxamethonium-induced hyperkalaemia 6 weeks after chemoradiotherapy in a patient with rectal carcinoma.
    Holak EJ; Connelly JF; Pagel PS
    Br J Anaesth; 2007 Jun; 98(6):766-8. PubMed ID: 17470846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Succinylcholine-induced "masseter spasm".
    Baraka A
    Middle East J Anaesthesiol; 1997 Jun; 14(2):73-6. PubMed ID: 9258882
    [No Abstract]   [Full Text] [Related]  

  • 9. Muscle relaxants and histamine release.
    Moss J
    Acta Anaesthesiol Scand Suppl; 1995; 106():7-12. PubMed ID: 8533551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Succinylcholine-induced hyperkalemia and rhabdomyolysis in a patient with necrotizing pancreatitis.
    Matthews JM
    Anesth Analg; 2000 Dec; 91(6):1552-4, TOC. PubMed ID: 11094017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case of leptosuccin induced malignant hyperthermia in a patient with GIST of the rectum.
    Natasa N; Snezana P; Nemanja Z; Zoran K; Durasić L
    Acta Chir Iugosl; 2012; 59(2):121-3. PubMed ID: 23373371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac arrhythmia after succinylcholine administration in a patient with Guillain-Barré syndrome--a case report.
    Hor JY
    Middle East J Anaesthesiol; 2010 Oct; 20(6):881-3. PubMed ID: 21526679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac arrest from succinylcholine-induced hyperkalemia.
    Huggins RM; Kennedy WK; Melroy MJ; Tollerton DG
    Am J Health Syst Pharm; 2003 Apr; 60(7):694-7. PubMed ID: 12701553
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuromuscular blocking drugs.
    Walts LF
    Otolaryngol Clin North Am; 1981 Aug; 14(3):501-13. PubMed ID: 7029408
    [No Abstract]   [Full Text] [Related]  

  • 15. Adverse reactions and interactions of the neuromuscular blocking drugs.
    Ostergaard D; Engbaek J; Viby-Mogensen J
    Med Toxicol Adverse Drug Exp; 1989; 4(5):351-68. PubMed ID: 2682131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suxamethonium, masseter spasm and later malignant hyperthermia.
    Ramirez JA; Cheetham ED; Laurence AS; Hopkins PM
    Anaesthesia; 1998 Nov; 53(11):1111-6. PubMed ID: 10023282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Chronology for the Identification and Disclosure of Adverse Effects of Succinylcholine.
    Huang L; Sang CN; Desai MS
    J Anesth Hist; 2019 Jul; 5(3):65-84. PubMed ID: 31570201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The response of patients with neuromuscular disorders to muscle relaxants: a review.
    Azar I
    Anesthesiology; 1984 Aug; 61(2):173-87. PubMed ID: 6087697
    [No Abstract]   [Full Text] [Related]  

  • 19. Neuromuscular and mitochondrial disorders: what is relevant to the anaesthesiologist?
    Driessen JJ
    Curr Opin Anaesthesiol; 2008 Jun; 21(3):350-5. PubMed ID: 18458553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Succinylcholine: changes in labeling.
    Bedford RF
    Anesth Analg; 1995 Oct; 81(4):883. PubMed ID: 7574032
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.